| Literature DB >> 26783464 |
George Galyfos1, Ioannis Stamatatos1, Stavros Kerasidis1, Ioannis Stefanidis1, Sotirios Giannakakis1, Georgios Kastrisios1, Georgios Geropapas1, Gerasimos Papacharalampous1, Chrisostomos Maltezos1.
Abstract
Objective. Aim of this study is to present the experience of our institution in carotid body tumors (CBTs) treatment. Methods. All cases treated in a Vascular Surgery Department within 2.5 years (03/2013-09/2015) were retrospectively evaluated. Demographics, diagnostic, and treatment strategy were recorded. All patients with known CBT underwent ultrasound and magnetic resonance imaging preoperatively. All cases were classified according to the Shamblin type and evaluated by a radiologist, otolaryngologist, and anesthesiologist before and after surgery. Major outcomes included mortality, stroke, cranial nerve injury, and recurrence. Results. Overall, nine patients (mean age: 59.5 ± 16.3 years) with a total of ten CBTs were treated. There was no gender prevalence and most of the cases (55%) were asymptomatic. There were no functional or familial cases. There was only one bilateral case treated in a staged manner. No preoperative embolization of CBTs was performed. Mortality and stroke rates were null. No severe complication was observed in the early and late setting. No malignancy was recorded. Mean follow-up was 15.6 ± 7.8 months. Conclusions. Multidisciplinary management of patients with CBTs is imperative for optimal results, especially in type III tumors, bilateral or functional cases. After careful treatment planning and intraoperative manipulations, complications could be avoided even without preoperative embolization.Entities:
Year: 2015 PMID: 26783464 PMCID: PMC4689957 DOI: 10.1155/2015/969372
Source DB: PubMed Journal: Int J Vasc Med ISSN: 2090-2824
Figure 1Intraoperative image showing a carotid artery bifurcation and a type II carotid body tumor.
Demographic data of patients included in the study.
| Variable | Mean values or number |
|---|---|
| Number of patients | 9 |
| Number of tumors resected | 10 |
| Age | 59.5 ± 16.3 years |
| Male gender | 4 (45%) |
| Bilateral tumors | 1 (11%) |
| Family history | 0 |
| Presentation | |
| Painless mass | 3 (33%) |
| Flushing/palpitations | 0 |
| Incidental discovery | 6 (67%) |
| Syncope/presyncope | 0 |
| Painful mass | 0 |
| Dysphagia/dysgeusia | 0 |
| Dysphonia | 0 |
| Amaurosis | 0 |
| Imaging | |
| Ultrasound duplex scan | 9 (100%) |
| Computed tomography | 0 |
| Digital angiography | 1 (11%) |
| Magnetic resonance angiography | 8 (89%) |
Management of patients included in the study.
| Variable | Mean values or number |
|---|---|
| Preoperative embolization | 0 |
| Resection alone | 8 (80%) |
| Prosthetic patch | 0 |
| Saphenous graft interposition | 2 (20%) |
| Primary end-to-end anastomosis | 0 |
| Shamblin classification | |
| Type I | 4 (40%) |
| Type II | 4 (40%) |
| Type III | 2 (20%) |
Outcomes, complications, and follow-up of patients.
| Variable | Mean values or number |
|---|---|
| Intraoperative | |
| Death | 0 |
| Stroke | 0 |
| Cranial nerve resection | 0 |
| Severe bradycardia or hypotension | 2 (20%) |
| Major bleeding/vascular injury | 0 |
| Operating time (minutes) | 113 ± 18 |
| Postoperative | |
| Respiratory failure | 0 |
| Hematoma | 0 |
| Reintervention | 0 |
| Infection | 0 |
| Cranial nerve injury | 0 |
| Death | 0 |
| Stroke | 0 |
| Follow-up (months) | 15.6 ± 7.8 |
| Recurrence rate | 0 |
Figure 2Intraoperative image showing the intact carotid bifurcation after the excision of a carotid body tumor.
Figure 3Magnetic resonance image showing a type II carotid body tumor (black arrows) that partially surrounds and compresses the carotid vessels (white arrows).